Dataset Information


Potent Pyrimidine and Pyrrolopyrimidine Inhibitors of Testis-Specific Serine/Threonine Kinase?2 (TSSK2).

ABSTRACT: Testis-specific serine/threonine kinase?2 (TSSK2) is an important target for reversible male contraception. A high-throughput screen of ?17?000 compounds using a mobility shift assay identified two potent series of inhibitors having a pyrrolopyrimidine or pyrimidine core. The pyrrolopyrimidine 10 (IC50 22?nm; GSK2163632A) and the pyrimidine 17 (IC50 31?nm; ALK inhibitor?1) are the most potent TSSK2 inhibitors in these series, which contain the first sub-100 nanomolar inhibitors of any TSSK isoform reported, except for the broad kinase inhibitor staurosporine. The novel, potent pyrimidine TSSK2 inhibitor compound 19 (IC50 66?nm; 2-[[5-chloro-2-[2-methoxy-4-(1-methylpiperidin-4-yl)anilino]pyrimidin-4-yl]amino]-N-methylbenzenesulfonamide) lacks the potential for metabolic activation. Compound 19 had a potency rank order of TSSK1>TSSK2>TSSK3>TSSK6, indicating that potent dual inhibitors of TSSK1/2 can be identified, which may be required for a complete contraceptive effect. The future availability of a TSSK2 crystal structure will facilitate structure-based discovery of selective TSSK inhibitors from these pyrrolopyrimidine and pyrimidine scaffolds.

SUBMITTER: Hawkinson JE 

PROVIDER: S-EPMC5962959 | BioStudies | 2017-01-01

REPOSITORIES: biostudies

Similar Datasets

2011-01-01 | S-EPMC3002843 | BioStudies
2016-01-01 | S-EPMC4866589 | BioStudies
2008-01-01 | S-EPMC2670491 | BioStudies
2020-01-01 | S-EPMC7401350 | BioStudies
2019-01-01 | S-EPMC6467197 | BioStudies
2011-01-01 | S-EPMC3079198 | BioStudies
2016-01-01 | S-EPMC4832243 | BioStudies
2018-01-01 | S-EPMC5890689 | BioStudies
2016-01-01 | S-EPMC5150693 | BioStudies
2018-01-01 | S-EPMC6099574 | BioStudies